Other Liabilities, Noncurrent of Y-mAbs Therapeutics, Inc. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Y-mAbs Therapeutics, Inc. quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending 30 Jun 2025 was $935,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $935,000 +$88,000 +10% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $851,000 -$2,000 -0.23% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $812,000 -$52,000 -6% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $897,000 +$75,000 +9.1% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $847,000 +$31,000 +3.8% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $853,000 +$36,000 +4.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $864,000 +$62,000 +7.7% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $822,000 +$89,000 +12% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $816,000 +$36,000 +4.6% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $817,000 -$18,000 -2.2% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $802,000 -$49,000 -5.8% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $733,000 -$138,000 -16% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $780,000 -$159,000 -17% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $835,000 -$1,099,000 -57% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $851,000 -$1,117,000 -57% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $871,000 -$1,052,000 -55% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $939,000 -$790,000 -46% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,934,000 +$1,477,000 +323% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,968,000 +$1,726,000 +713% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,923,000 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,729,000 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $457,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $242,000 +$18,000 +8% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $224,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.